DJIA 18,037.97 -42.17 -0.23%
NASDAQ 5,060.25 -31.84 -0.63%
S&P 500 2,108.92 -8.77 -0.41%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)

13.21 -0.21 (-1.56%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SRPT $13.21 -1.56%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.48
Previous Close $13.42
Daily Range $12.93 - $13.94
52-Week Range $11.33 - $38.25
Market Cap $545.7M
P/E Ratio -4.78
Dividend (Yield) $0.00 (0.0%)
Volume 841,557
Average Daily Volume 754,797
Current FY EPS -$4.10




Drug Makers

Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website:

News & Commentary

10 Most Hated Companies in Healthcare

When emotional trading is on display, the short-sellers come out to play. Find out which companies are the most hated in healthcare, why they're so universally disliked, and which company may eventually deserve a reprieve.

Santhera -- A Duchenne Drug With Positive Study Results That Few Know About

Tekmira Up on Ebola Candidate Update from the FDA - Analyst Blog

Sarepta's Long Road Ahead

Has the Biotech Bubble Already Popped?

Fear about a bubble in biotech is growing, keeping many investors on the sidelines. Is this fear warranted?

CNBC's Stock Pops & Drops From April 1: GoPro, Michael Kors, Delta, Sarepta

Sarepta CEO Exits, Eteplirsen Regulatory Filing on Track - Analyst Blog

What Does Sarepta's Big CEO Shakeup Mean?

Morning Market Gainers

Sarepta Therapeutics Inc.'s CEO Exits: Is the Stock Now a Buy?

Sarapeta's CEO abruptly left the company yesterday. With a new face at the helm, can this speculative biotech finally change course?

See More SRPT News...

SRPT's Top Competitors

SRPT $13.21 (-1.56%)
Current stock: SRPT
AMGN $162.38 (-3.29%)
Current stock: AMGN
GILD $102.94 (-0.73%)
Current stock: GILD
BIIB $389.27 (-3.10%)
Current stock: BIIB